MedPath

Clinical and Radiographic Evaluation of MTA Pulpotomy Versus Conventional Pulpectomy in Primary Molars With Irreversible Pulpitis

Not Applicable
Not yet recruiting
Conditions
Decayed Primary Molars With Irreversible Pulpitis
Registration Number
NCT06751316
Lead Sponsor
Cairo University
Brief Summary

This study is designed to compare between MTA Pulpotomy (Removal of coronal pulp tissue, placing MTA and covering with Stainless steel crown) Versus Conventional Pulpectomy (Removal of radicular pulp tissue, placing Zinc Oxide/Eugenol and covering with Stainless steel crown) in irreversible pulpitis in primary second molars.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Patients:
  • Aged 4-7 years, cooperative, in good general health and medically within normal
  • Teeth:
  • Restorable mandibular second primary molars.
  • History of irreversible pulpitis.
  • Preoperative radiograph:
  • Absence of periapical or inter-radicular radiolucency.
  • Absence of widening of periodontal ligaments (PDL) space.
  • Absence of internal or external root resorption.
Exclusion Criteria
  • Patients:
  • With systemic disorders.
  • Physical or mental disabilities.
  • Unable to attend follow- up visits.
  • Refusal of Participation.
  • Refusal to sign the informed consent.
  • Teeth:
  • Previously accessed teeth.
  • Mobile mandibular second primary molar.
  • Swelling in the vestibule or on palpation.
  • Pain on percussion.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
• rate of clinical success12 months

* tenderness on percussion and palpation

* sinus/parulis/fistula

* soft tissue swelling

* pathological mobility

Secondary Outcome Measures
NameTimeMethod
• rate of radiographic success12 months

* pathologic root resorption.

* interradicular and/or periapical radiolucency

Trial Locations

Locations (1)

Cairo University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath